SCHEMBL18158545

SCHEMBL18158545

COc1cc2ncnc(Nc3ccc(Oc4ccc(Cl)cc4)cc3C)c2cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.68
SRC P12931 4/20 0.67
FLT1 P17948 3/20 0.64
EPHB2 P29323 2/20 0.64
FGFR1 P11362 2/20 0.64
FLT4 P35916 2/20 0.64
RET P07949 4/20 0.62
KIF5B P33176 3/20 0.62
EGFR P00533 9/20 0.61
RIPK2 O43353 2/20 0.59
NOD1 Q9Y239 1/20 0.57
EPHA2 P29317 1/20 0.56
EPHB4 P54760 1/20 0.56
LCK P06239 2/20 0.56
MAPK1 P28482 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
GMNN O75496 1/20 0.55
ALDH1A1 P00352 1/20 0.55
ABL1 P00519 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18158240 0.91 KDR (0.65) KDRSRCFLT1EPHB2FGFR1
SCHEMBL18158540 0.91 KDR (0.64) KDRSRCFLT1EPHB2FGFR1
SCHEMBL29464032 0.90 EGFR (0.73) KDRSRCFLT1EPHB2RET
SCHEMBL30844364 0.90 EGFR (0.73) KDRSRCFLT1EPHB2RET
SCHEMBL18153627 0.90 EGFR (0.73) KDRSRCFLT1EPHB2RET
Hydrochloric Acid SCHEMBL29360029 0.89 EGFR (0.72) KDRSRCFLT1EPHB2RET
Hydrochloric Acid SCHEMBL18153640 0.89 EGFR (0.72) KDRSRCFLT1EPHB2RET
SCHEMBL8933814 0.85 KDR (0.88) KDRSRCFLT1EPHB2FLT4
Hydrochloric Acid SCHEMBL8808201 0.84 KDR (0.86) KDRSRCFLT1EPHB2FLT4
SCHEMBL18158267 0.83 EGFR (0.76) KDRSRCFLT1EPHB2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10548897-B2 KSR antagonists ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2020-02-04 US disclosed
WO-2016168704-A1 KSR ANTAGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10548897-B2 KSR antagonists KSR1, KSR2, KRAS KDR 1123/4885SRC 133/4885FLT1 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.